Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.46 |
| ▸ | FOXM1 | Q08050 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 2/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4480785 | 0.98 | EPHX2 (0.49) | KMT2AALDH1A1MEN1EPHX2SGMS2 | |
| SCHEMBL28524004 | 0.96 | ALDH1A1 (0.43) | KMT2AALDH1A1MEN1EPHX2SGMS2 | |
| SCHEMBL17916423 | 0.84 | KDM1A (0.49) | ALDH1A1TSHR | |
| SCHEMBL28527816 | 0.84 | ALDH1A1 (0.43) | KMT2AALDH1A1MEN1EPHX2SGMS2 | |
| SCHEMBL20936679 | 0.82 | MAOB (0.47) | KMT2AALDH1A1MEN1 | |
| SCHEMBL30733533 | 0.82 | MAOB (0.47) | KMT2AALDH1A1MEN1 | |
| SCHEMBL994856 | 0.82 | MAOB (0.47) | KMT2AALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL994709 | 0.81 | MAOB (0.46) | KMT2AALDH1A1MEN1 | |
| SCHEMBL24067279 | 0.80 | ALDH1A1 (0.39) | KMT2AALDH1A1MEN1SGMS2FOXM1 | |
| SCHEMBL21903015 | 0.80 | KMT2A (0.36) | KMT2AALDH1A1MEN1SGMS2FOXM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112390755-B | Heteroaryl method for amine | 中国科学院理化技术研究所 | 2024-08-02 | — | — | CN | disclosed |
| CN-112390755-A | Method for heteroarylation of amine | 中国科学院理化技术研究所 | 2021-02-23 | — | — | CN | disclosed |
| EP-2259790-A1 | ABCA-1 ELEVATING COMPOUNDS AND THE USE THEREOF | Gilead Palo Alto, Inc. (US) | 2010-12-15 | — | — | EP | disclosed |
| EP-2146967-A2 | TETRAHYDROINDOLE AND TETRAHYDROINDAZOLE DERIVATIVES | Serenex, Inc. (US) | 2010-01-27 | — | — | EP | disclosed |
| WO-2009100326-A1 | ABCA-1 ELEVATING COMPOUNDS AND THE USE THEREOF | CV THERAPEUTICS, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| WO-2008130879-A2 | TETRAHYDROINDOLE AND TETRAHYDROINDAZOLE DERIVATIVES | SERENEX, INC. (US) | 2008-10-30 | — | — | WO | disclosed |
| EP-1789431-A1 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | CV THERAPEUTICS, INC. (US) | 2007-05-30 | — | — | EP | disclosed |
| EP-1768991-A1 | PROCESS FOR THE PREPARATION OF A1-ADENOSINE RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2007-04-04 | — | — | EP | disclosed |
| WO-2006026651-A1 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | CV THERAPEUTICS, INC. (US) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006017052-A1 | PROCESS FOR THE PREPARATION OF A1 ADENOSINE RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2006-02-16 | — | — | WO | disclosed |
| EP-1334087-A1 | CYCLOALKYLFLUOROSULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2003-08-13 | — | — | EP | disclosed |
| WO-2002032858-A1 | CYCLOALKYLFLUOROSULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2002-04-25 | — | — | WO | disclosed |